[Federal Register Volume 85, Number 28 (Tuesday, February 11, 2020)]
[Notices]
[Pages 7760-7761]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-02691]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Chief Operating 
Officer, CDC, pursuant to Public Law 92-463. The

[[Page 7761]]

grant applications and the discussions could disclose confidential 
trade secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the grant 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)--RFA-CE-20-003, Research Grants 
for Preventing Violence and Violence Related Injury.
    Date: April 1-2, 2020.
    Time: 8:30 a.m.-5:30 p.m., EDT.
    Place: Embassy Suites Buckhead, 3285 Peachtree Road NE, Atlanta, GA 
30305.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Kimberly Leeks, Ph.D., M.P.H., 
Scientific Review Official, NCIPC, CDC, 4770 Buford Highway NE, 
Building 106, MS S106-9, Atlanta, Georgia 30341, Telephone: (770) 488-
6562, [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-02691 Filed 2-10-20; 8:45 am]
BILLING CODE 4163-18-P